Familial prostate cancer: A different disease?

Journal of Urology

Volumn 158, Issue 6, 1997, Pages 2197-2201

  Kupelian, Patrick A ^a   Klein, Eric A ^b   Witte, John S ^b   Kupelian, Varant A ^b   Suh, John H ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

Family; Prognosis; Prostate specific antigen; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGE; ARTICLE; CANCER SURVIVAL; FAMILIAL CANCER; FAMILY HISTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TREATMENT OUTCOME;

EID: 0030813226     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)68194-1     Document Type: Article

References (8)

1. Carter, B. S., Bova, G. S., Beaty, T. H., Steinberg, G. D., Childs, B., Isaacs, W. B. and Walsh, P. C.: Hereditary prostate cancer: epidemiologic and clinical features. J. Urol., 150: 797, 1993.
2. Bastacky, S. I., Wojno, K. J., Walsh, P. C., Carmichael, M. J. and Epstein, J. I.: Pathological features of hereditary prostate cancer. J. Urol., 153: 987, 1995.
3. Bova, G. S., Isaacs, S. D., Partin, A. W., Isaacs, W. B. and Walsh, P. C.: Biological aggressiveness of hereditary prostate cancer (HPC): long term evaluation following radical prostatectomy (RRP). J. Urol., part 2, 153: 505A, abstract 1105, 1995.
4. Partin, A. W., Pound, C. R., Clemens, J. Q., Epstein, J. I. and Walsh, P. C.: Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol. Clin. N. Amer., 20: 713, 1993.
5. Harris, E. and Albert, A.: Survivorship analysis for clinical studies. 5-125, 1991.
6. Kupelian, P., Katcher, J., Levin, H., Zippe, C. and Klein, E.: Correlation of clinical and pathologic factors with rising prostate specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. Urology, 48: 249, 1996.
7. Kupelian, P. A., Kupelian, V. A., Witte, J. S., Macklis, R. and Klein, E. A.: Family history of prostate cancer in patients with localized prostate cancer: an independent predictor of treatment outcome. J. Clin. Oncol., 15: 1478, 1997.
8. Smith, J. R., Freije, D., Carpten, J. D., Gronberg, H., Xu, J., Issacs, S. D., Brownstein, M. J., Bova, G. S., Guo, H., Bujnovsky, P., Nusskern, D. R., Damber, J. E., Bergh, A., Emanuelsson, M., Kallioniemi, O. P., Walker-Daniels, J., Bailey-Wilson, J. E., Beaty, T. H., Meyers, D. A., Walsh, P. C., Collins, F. S., Trent, J. M. and Isaacs, W. B.: Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science, 274: 1371, 1996.